Cargando…
Montelukast: its role in the treatment of childhood asthma
The cysteinyl leukotrienes, LTC(4), LTD(4), and LTE(4), play an integral role in the pathophysiology of asthma. Acting via the type 1 leukotriene (CysLT(1)) receptor, these proinflammatory mediators have numerous effects in the lungs, including decreased activity of respiratory cilia, increased mucu...
Autor principal: | Harmanci, Koray |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376066/ https://www.ncbi.nlm.nih.gov/pubmed/18473012 |
Ejemplares similares
-
Exercise-induced asthma: critical analysis of the protective role of montelukast
por: Carver, Terrence W
Publicado: (2009) -
Role of Montelukast in Asthma and Allergic rhinitis patients
por: Zuberi, Faisal Faiyaz, et al.
Publicado: (2020) -
Asthma phenotypes: the intriguing selective intervention with Montelukast
por: Marcello, Cottini, et al.
Publicado: (2016) -
Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients
por: Scichilone, Nicola, et al.
Publicado: (2013) -
The Editors Respond: The Diminishing Role of Montelukast in Asthma Therapy
por: Crownover, Brian K., et al.
Publicado: (2006)